| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2010 | US7741465 Chimeric receptor genes and cells transformed therewith |
| 06/22/2010 | US7741454 Biological low-molecular-weight derivatives |
| 06/22/2010 | US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation |
| 06/22/2010 | US7741447 Antibody against tumor specific antigen as target |
| 06/22/2010 | US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients |
| 06/22/2010 | US7741439 Isolated stra6 polypeptides |
| 06/22/2010 | US7741374 Treating dyslipidemia with meal-independent immediate release dosage form of fenofibric acid |
| 06/22/2010 | US7741373 Treating hypertriglyceridemia with meal-independent immediate release dosage form of fenofibric acid |
| 06/22/2010 | US7741372 Targeting p38 mitogen activated protein kinase (MAPK) cellular signaling pathway; using such as N,N'-bis(3,5-diacetylphenyl)decanediamide tetrakis(amidinohydrazone) tetrahydrochloride |
| 06/22/2010 | US7741371 antiandrogens useful for suppressing spermatogenesis, treating hormone related conditions and prostate cancer; hormone inhibitors |
| 06/22/2010 | US7741370 calcium and magnesium double salts of (-)-hydroxycitric acid, used for reducing obesity, treating osteoporosis, and as dietary, beverages or nutraceutical supplements; water solubility |
| 06/22/2010 | US7741369 Lipoxin compounds and their use in treating cell proliferative disorders |
| 06/22/2010 | US7741368 Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs |
| 06/22/2010 | US7741367 Method of using abscisic acid to treat diseases and disorders |
| 06/22/2010 | US7741366 mixing aqueous Solution "A" containing a salt of an organic acid ( sodium citrates, sodium glylcolate, sodium lactate) in presence of a reducing salt of sodium metabisulfites or sodium hydrosulfites with Solution "B" containing aqueous solution of a water soluble H2O2; pH control; antiacne, fungicide |
| 06/22/2010 | US7741365 Dibenzo[b,d]pyran-6-ones used for providing a physiological effect to treat pain, pain associated with cancer, chemotherapy, neuropathy, Multiple Sclerosis, Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and inflammation; antinociceptive agents |
| 06/22/2010 | US7741363 And 3-oximidoindole derivatives; cannabinoid receptor antagonists; cardiovascular, gastrointestinal, autoimmune, and neurodegenerative disorders; obesity, infections; antidiabetic and antiallergen agents; acylation, oximination |
| 06/22/2010 | US7741362 4-amino-(S)-2-N-(4-methyl-1-naphthalenesulfonyl)amino-N'-(1,2,3,4-tetrahydro-1-naphthyl)butanamide, arylsulfonylamino based peptidomimetics used for imaging tissues and/or organs such as brain, blood vessels or tumors; medical diagnosis |
| 06/22/2010 | US7741361 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/22/2010 | US7741360 such as [4-Acetylamino-3-(biphenyl-4-ylsulfanyl)-2-methyl-indol-1-yl]-acetic acid, ligands for orphan receptors, used the treatment of respiratory sytem disorders, including asthma, rhinitis and chronic obstructive pulmonary disease |
| 06/22/2010 | US7741359 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 06/22/2010 | US7741358 Crystal form of asenapine maleate |
| 06/22/2010 | US7741356 Compounds as opioid receptor modulators |
| 06/22/2010 | US7741355 Small-molecule modulators of TRP-p8 activity |
| 06/22/2010 | US7741354 Neuroproptective drug; Parkinson's disease; immunomoderators; enzyme inhibitors; immunosuppressants; antihistamines; alzheimer's disease; Down's syndrome; Huntington disease |
| 06/22/2010 | US7741353 Lead-free primary explosives |
| 06/22/2010 | US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence |
| 06/22/2010 | US7741351 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 06/22/2010 | US7741350 Bicyclic pyrazolo-heterocycles |
| 06/22/2010 | US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 06/22/2010 | US7741348 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 06/22/2010 | US7741347 Hepatitis C virus inhibitors |
| 06/22/2010 | US7741346 Vision defects; anticancer agents; antitumor agents |
| 06/22/2010 | US7741345 HIV proteases as therapeutic agents for inhibition and treatment of HIV infection in humans, administered in combination with other classes of HIV therapeutic agents, especially inhibitors of HIV reverse transcriptase |
| 06/22/2010 | US7741344 resolution of racemic mixture of 6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one (BEL), using chromatography; enzyme inhibtors used to determining the role of specific isoforms of Calcium-independent phospholipases A2 (iPLA2s) |
| 06/22/2010 | US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/22/2010 | US7741342 Water-soluble thalidomine derivatives |
| 06/22/2010 | US7741341 Benzimidazole-derivatives as factor Xa inhibitors |
| 06/22/2010 | US7741340 Hydroxy piperidine derivatives to treat gaucher disease |
| 06/22/2010 | US7741339 Fab I inhibitors |
| 06/22/2010 | US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation |
| 06/22/2010 | US7741337 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 06/22/2010 | US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer |
| 06/22/2010 | US7741335 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis |
| 06/22/2010 | US7741334 administering Elvucitabine for treatment of hepatitis B and/or human immunodeficiency virus |
| 06/22/2010 | US7741333 (3-bromophenyl)-(3,3-dioxo-2,3-dihydro-1H-3 lambda 6-thia-6,8-diazacyclopenta[a]naphthalen-9-yl)amine, uses as inhibitors of protein kinases |
| 06/22/2010 | US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines |
| 06/22/2010 | US7741331 Use treating atherosclerosis, angiogenesis, type II diabetes, diabetic retinopathy, cancer, and asthma; for example, 3-ethyl-1-propyl-8-(1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl)-1,3,7-trihydropurine-2,6-dione |
| 06/22/2010 | US7741330 1-((S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)-2,3-dihydroxypropan-1-one, used for the treatment of autoimmune diseases, inflammatory diseases, allergy disorders, B-cell proliferative disorders, or thromboembolic disorders |
| 06/22/2010 | US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 06/22/2010 | US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds |
| 06/22/2010 | US7741327 Pyrrolidinone glucokinase activators |
| 06/22/2010 | US7741326 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands |
| 06/22/2010 | US7741325 Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds |
| 06/22/2010 | US7741324 Imidazotriazines as protein kinase inhibitors |
| 06/22/2010 | US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction |
| 06/22/2010 | US7741322 Isoquinolinone potassium channel inhibitors |
| 06/22/2010 | US7741321 Modulators of ATP-binding cassette transporters |
| 06/22/2010 | US7741320 6,7-dichloro-4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide, used as AMPA receptor modulators for the treatment of anxiety, depression, Parkinson's disease, Pick's disease, Huntington's chorea, Korsakoff's disease and schizophrenia |
| 06/22/2010 | US7741319 11-hydroxy-5h-pyrrolo[2,1-c][1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines |
| 06/22/2010 | US7741318 used for treating central nervous system diseases such as depression, cognitive diseases and neurodegenerative diseases such as Parkinson's disease, alzheimer's disease or psychoses, and stroke |
| 06/22/2010 | US7741317 LXR modulators |
| 06/22/2010 | US7741316 Pharmacological uses of azetidine derivatives |
| 06/22/2010 | US7741315 such as 11-(3-chloro-4-fluorobenzyl)-9-hydroxy-2-methyl-3,4,5,6,12,13-hexahydro-2H-[1,4]-diazocino[2,1-a]-2,6-naphthyridine-1,8,10(11H)-trione, used for the prophylaxis or treatment of infection by HIV and/or delay in the onset of AIDS |
| 06/22/2010 | US7741314 anticarcinogenic agent; arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte; inhibiting adipocyte differentiation and stearoyl CoA desaturase (SCD-1) gene transcription; skin disorder, psoriasis, obesity, antiinflammatory agent |
| 06/22/2010 | US7741313 administering 17(E)-1 alpha ,25-dihydroxy-17(20)-dehydro-2-methylene-19-nor-vitamin D3, for the treatment of acne, obesity, hypertension, cancer and skin diseases |
| 06/22/2010 | US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/22/2010 | US7741311 Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing |
| 06/22/2010 | US7741310 A polynucleotide encodes an arginase, a nerve growth factors for treating nervous system disorders, neurodegenerative diseases |
| 06/22/2010 | US7741308 DBAIT and uses thereof |
| 06/22/2010 | US7741307 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2 |
| 06/22/2010 | US7741304 delivering an antisense oligonucleotide to the tumor, wherein antisense oligonucleotide hybridizes to casein kinase 2 nucleic acid sequences and reduces the expression thereof,of casein kinase 2, results in a reduction in size of such tumor |
| 06/22/2010 | US7741303 Stimulation of cellular regeneration and differentiation in the inner ear |
| 06/22/2010 | US7741299 pulmonary disorders, microvascular disorders, eye diseases (glaucoma) and respiratory conditions |
| 06/22/2010 | US7741298 Using interfering Rna; blocking antibodies |
| 06/22/2010 | US7741296 via acyclic nucleoside analogs such as acyclovir and penciclovir; apoptosis |
| 06/22/2010 | US7741295 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
| 06/22/2010 | US7741292 Method of inhibiting the emigration of cells from the intravascular compartment into tissues |
| 06/22/2010 | US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 06/22/2010 | US7741285 APO-2 ligand/trail formulations |
| 06/22/2010 | US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 06/22/2010 | US7741244 Synergistic combination of fatty acid with such as glycolic acid; nonphytotoxic, wide spectrum; safe |
| 06/22/2010 | US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor |
| 06/22/2010 | US7741030 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not |
| 06/22/2010 | US7740884 Freeze-dried FSH/LH formulations |
| 06/22/2010 | US7740881 Method of treating humans with opioid formulations having extended controlled release |
| 06/22/2010 | US7740880 mixing a small interfering RNA with a conjugate comprising a cholesterol residue covalently bonded to oligoarginine through a formate residue linker, thereby forming the complex; carrier for delivery of an siRNA targeted to vascular endothelial growth factor for the treatment for cancer |
| 06/22/2010 | US7740878 Use of betaine to enhance exercise performance |
| 06/22/2010 | US7740874 A white petrolatum and a methyl glucose dioleate emulsifier selected for its hydrophilic-lipophilic balance, compatibility and as a neutral, nonionic absorption base whose use or permits low production temperatures; especially effective for a hydrocarotizone formulation; cosmetics; stabilizers-free |
| 06/22/2010 | US7740873 Radiation transparent; softness, gloss, residue-free; mixture of polysiloxane and fatty alcohol |
| 06/22/2010 | US7740839 Extracellular superoxide dismutase (EC SOD); fusion proteins; tat domains; cosmetics; skin disorders |
| 06/22/2010 | US7740831 Compositions for potentiating glutathione |
| 06/22/2010 | US7740830 Imaging, diagnosis and treatment of disease |
| 06/22/2010 | US7740463 Pressurised metered dose inhalers (MDI) |
| 06/22/2010 | CA2688614A1 Phenyl-butoxy-phenyl-ethynyl substituted indole compounds having cyslt1/cyslt2 receptor antagonistic activity |
| 06/22/2010 | CA2591515C Pharmaceutical formulations of gallium salts |
| 06/22/2010 | CA2586538C Nitroxy steroids |
| 06/22/2010 | CA2579915C Indole derivatives and their use as inhibitors of p53-mdm2 interaction |
| 06/22/2010 | CA2563325C Oral modified-release lozenges and their preparation method |
| 06/22/2010 | CA2549672C Antineutrophilia agent using 3(2h)-pyridazinone compounds |